Interrelations and associations of serum levels of steroids and pituitary hormones with markers of insulin resistance, inflammatory activity, and renal function in men and women aged >70 years in an 8-year longitudinal study of opposite-sex twins

Gender Medicine

Volumn 6, Issue SUPPL. 1, 2009, Pages 123-136

  Brismar, Kerstin ^a   Nilsson, Sven E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

age; cortisol; CRP; cystatin; estradiol; FSH; insulin resistance; LH; progesterone; prolactin; renal function; sex; testosterone; urea

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; HYPOPHYSIS HORMONE; INSULIN; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; STEROID HORMONE; TESTOSTERONE; UREA;

AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; LONGITUDINAL STUDY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; REGISTER; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TWINS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; PITUITARY HORMONES; REGISTRIES; SEX FACTORS; STATISTICS AS TOPIC; SWEDEN; TWINS;

EID: 62649132426     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.01.001     Document Type: Article

References (38)

1. Bélanger A., Candas B., Dupont A., et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79 (1994) 1086-1090
2. Lamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 (1997) 419-424
3. Orentreich N., Brind J.L., Vogelman J.H., et al. Longterm longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75 (1992) 1002-1004
4. Van Cauter E., Leproult R., and Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81 (1996) 2468-2473
5. Vermeulen A., and Kaufman J.M. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res 43 (1995) 25-28
6. Vermeulen A., Kaufman J.M., and Giagulli V.A. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81 (1996) 1821-1826
7. Cederlöf R., and Lorich U. The Swedish Twin Registry. In: Nance W.E., Allen G., and Parisi P. (Eds). Part C: Biology and Epidemiology. Progress in Clinical and Biological Research. Twin Research: Proceedings of the Second International Congress on Twin Studies, August 29-September 1, 1977, Washington, DC (1978), Alan R. Liss, New York, NY 189-195
8. Gold C.H., Malmberg B., McClearn G.E., et al. Gender and health: A study of older unlike-sex twins. J Gerontol B Psychol Sci Soc Sci 57 (2002) S168-S176
9. International Statistical Classification of Diseases and Related Health Problems. 10th Revision (1992), World Health Organization, Geneva, Switzerland
10. Nilsson S.E., Evrin P.E., Tryding N., et al. Biochemical values in persons older than 82 years of age: Report from a population-based study of twins. Scand J Clin Lab Invest 63 (2003) 1-13
11. In: Tietz N.W. (Ed). Clinical Guide to Laboratory Tests. 3rd ed (1995), WB Saunders Company, Philadelphia, Pa
12. Meden-Vrtovec H., and Kocijancic A. Periovulatory serum prolactin and progesteron secretion in gonadotropin stimulated cycles. Acta Eur Fertil 19 (1988) 213-216
13. Missmer S.A., Spiegelman D., Bertone-Johnson E.R., et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15 (2006) 972-978
14. Braun M.M., Ahlbom A., Floderus B., et al. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 6 (1995) 519-524
15. Unden A.L., Elofsson S., Knox S., et al. IGF-I in a normal population: Relation to psychosocial factors. Clin Endocrinol (Oxf) 57 (2002) 793-803
16. In: Yen S.S.C., and Jaffe R.B. (Eds). Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 3rd ed (1991), WB Saunders, Philadelphia, Pa
17. Westberg L., Ho H.P., Baghaei F., et al. Polymorphisms in oestrogen and progesterone receptor genes: Possible influence on prolactin levels in women. Clin Endocrinol (Oxf) 61 (2004) 216-223
18. Jain S.K., Kannan K., Prouty L., and Jain S.K. Progesterone, but not 17beta-estradiol, increases TNF-alpha secretion in U937 monocytes. Cytokine 26 (2004) 102-105
19. Schneider H.P. Androgens and antiandrogens. Ann N Y Acad Sci 997 (2003) 292-306
20. Crandall C., Palla S., Reboussin B., et al. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. J Womens Health (Larchmt) 15 (2006) 14-23
21. Gorodeski G.I. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol 16 (2002) 329-355
22. Heiss G., Wallace R., Anderson G.L., et al., for the WHI Investigators. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299 (2008) 1036-1045
23. Howard B.V., Hsia J., Ouyang P., et al. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation 110 (2004) 201-206
24. Jeanes H.L., Wanikiat P., Sharif I., and Gray G.A. Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemiareperfusion injury. Menopause 13 (2006) 80-86
25. Picard F., Wanatabe M., Schoonjans K., et al. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to betacell proliferation. Proc Natl Acad Sci U S A 99 (2002) 15644-15648
26. Wassmann S., and Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 24 (2006) S15-S21
27. Schumacher M., Guennoun R., Ghoumari A., et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28 (2007) 387-439
28. Parker Jr. C.R., Slayden S.M., Azziz R., et al. Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85 (2000) 48-54
29. Chilton B.S., and Hewetson A. Prolactin and growth hormone signaling. Curr Top Dev Biol 68 (2005) 1-23
30. Serri O., Li L., Mamputu J.C., et al. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: Effects of cabergoline therapy. Clin Endocrinol (Oxf) 64 (2006) 366-370
31. Raaz D., Wallaschofski H., Stumpf C., et al. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 38 (2006) 767-772
32. Wallaschofski H., Lohmann T., Hild E., et al. Enhanced platelet activation by prolactin in patients with ischemic stroke. Thromb Haemost 96 (2006) 38-44
33. Glasow A., Breidert M., Haidan A., et al. Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab 81 (1996) 3103-3111
34. Hügl S.R., and Merger M. Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins. JOP 8 (2007) 739-752
35. Orbach H., and Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 6 (2007) 537-542
36. Qazi A.M., Tsai-Morris C.H., and Dufau M.L. Ligand-independent homo- and heterodimerization of human prolactin receptor variants: Inhibitory action of the short forms by heterodimerization. Mol Endocrinol 20 (2006) 1912-1923
37. Juul A., and Skakkebaek N.E. Androgens and the ageing male. Hum Reprod Update 8 (2002) 423-433
38. Tibblin G., Adlerberth A., Lindstedt G., et al. The pituitary-gonadal axis and health in elderly men: A study of men born in 1913. Diabetes 45 (1996) 1605-1609